ST316 interfered with β-catenin immune-exclusion allowing for stronger cytotoxic T-cell activity. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ST316 for the treatment ...
The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...
(HealthDay News) — In a case first reported in Louisiana last Friday, a patient has now developed the first known case of bird flu so severe as to require hospitalization, according to the US Centers ...
The investigational therapy combines doravirine, a non-nucleoside reverse transcriptase inhibitor, with islatravir, a nucleoside reverse transcriptase translocation inhibitor.
(HealthDay News) — Transcutaneous auricular vagus nerve stimulation (taVNS) reduces insomnia severity, according to a study published online Dec. 16 in JAMA Network Open.
No association seen for increased risks for dementia, cognitive impairment without dementia, accelerated cognitive decline ...
There is no indication that Luigi Mangione, the man charged with killing UnitedHealthcare CEO Brian Thompson, was ever a client of UnitedHealthcare, according to authorities.
LPCN 1148 is an oral prodrug of bioidentical testosterone containing testosterone dodecanoate, an androgen receptor agonist.
The BLA acceptance was supported by data from the randomized, placebo-controlled phase 2b/3 CLEVER trial as well as interim ...
The Food and Drug Administration (FDA) has approved Steqeyma ® (ustekinumab-stba), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases in adults and ...
(HealthDay News) — Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract disease (LRTD) among adults aged 60 years or older, according ...
Vitamin D supplementation, with or without calcium, offers no benefit for preventing falls or fractures in community-dwelling seniors ...